Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03134976 · ClinicalTrials.gov registry record

Wound Complications in Head and Neck Surgery

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
51
Enrollment target

NCT03134976 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03134976 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

This is a prospective observational study evaluating wound complications following head and neck surgery. Patients undergoing major head and neck surgery will be included in the study. Patients meeting eligibility criteria will be identified by members of the University of Michigan Head and Neck Oncology Division of the Department of Otolaryngology. The primary aim of this study is to identify risk factors for poor wound healing as well as biologic markers associated with wound related complications in head and neck surgery. Most specifically, this study evaluates the effects of thyroid hormone on wound healing. This study will also evaluate pre-operative labs and comorbidities as well as reconstructive factors, post-operative labs, and other variables associated with wound healing. All interventions regarding wound healing fall under current standards of care and standard practice. Data regarding post-operative wound complications will be collected in a prospective fashion on the variables under study using study-specific datasheets. Data sheet will be entered into a secure database for analysis.

Interventions

  • DRUG Levothyroxine

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2017-05-01
Est. Completion 2020-05-01

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03134976

The ClinicalTrials.gov registry entry for NCT03134976 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Levothyroxine is the first listed.

NCT03134976 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03134976 about?

NCT03134976 is a clinical study titled "Wound Complications in Head and Neck Surgery". This is a prospective observational study evaluating wound complications following head and neck surgery. Patients undergoing major head and neck surgery will be included in the study. Patients meeting eligibility criteria will be identified by members of the University of Michigan Head and Neck Onc...

What is the current status of trial NCT03134976?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2017-05-01. Estimated completion is 2020-05-01.

What interventions are being tested in trial NCT03134976?

The interventions under investigation include: Levothyroxine (DRUG).

Who is sponsoring clinical trial NCT03134976?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.